Literature DB >> 20379184

Fatty liver incidence and predictive variables.

Akira Tsuneto1, Ayumi Hida, Nobuko Sera, Misa Imaizumi, Shinichiro Ichimaru, Eiji Nakashima, Shinji Seto, Koji Maemura, Masazumi Akahoshi.   

Abstract

Although fatty liver predicts ischemic heart disease, the incidence and predictors of fatty liver need examination. The objective of this study was to determine fatty liver incidence and predictive variables. Using abdominal ultrasonography, we followed biennially through 2007 (mean follow-up, 11.6+/-4.6 years) 1635 Nagasaki atomic bomb survivors (606 men) without fatty liver at baseline (November 1990 through October 1992). We examined potential predictive variables with the Cox proportional hazard model and longitudinal trends with the Wilcoxon rank-sum test. In all, 323 (124 men) new fatty liver cases were diagnosed. The incidence was 19.9/1000 person-years (22.3 for men, 18.6 for women) and peaked in the sixth decade of life. After controlling for age, sex, and smoking and drinking habits, obesity (relative risk (RR), 2.93; 95% confidence interval (CI), 2.33-3.69, P<0.001), low high-density lipoprotein-cholesterol (RR, 1.87; 95% CI, 1.42-2.47; P<0.001), hypertriglyceridemia (RR, 2.49; 95% CI, 1.96-3.15; P<0.001), glucose intolerance (RR, 1.51; 95% CI, 1.09-2.10; P=0.013) and hypertension (RR, 1.63; 95% CI, 1.30-2.04; P<0.001) were predictive of fatty liver. In multivariate analysis including all variables, obesity (RR, 2.55; 95% CI, 1.93-3.38; P<0.001), hypertriglyceridemia (RR, 1.92; 95% CI, 1.41-2.62; P<0.001) and hypertension (RR, 1.31; 95% CI, 1.01-1.71; P=0.046) remained predictive. In fatty liver cases, body mass index and serum triglycerides, but not systolic or diastolic blood pressure, increased significantly and steadily up to the time of the diagnosis. Obesity, hypertriglyceridemia and, to a lesser extent, hypertension might serve as predictive variables for fatty liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379184     DOI: 10.1038/hr.2010.45

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  19 in total

Review 1.  Social networks and future direction for obesity research: A scoping review.

Authors:  Soohyun Nam; Nancy Redeker; Robin Whittemore
Journal:  Nurs Outlook       Date:  2014-11-06       Impact factor: 3.250

2.  Bi-directional analysis between fatty liver and cardiovascular disease risk factors.

Authors:  Jiantao Ma; Shih-Jen Hwang; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Raymond T Chung; Emelia J Benjamin; Daniel Levy; Caroline S Fox; Michelle T Long
Journal:  J Hepatol       Date:  2016-10-10       Impact factor: 25.083

3.  Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.

Authors:  Karina Banasik; Johanne M Justesen; Malene Hornbak; Nikolaj T Krarup; Anette P Gjesing; Camilla H Sandholt; Thomas S Jensen; Niels Grarup; Asa Andersson; Torben Jørgensen; Daniel R Witte; Annelli Sandbæk; Torsten Lauritzen; Bernard Thorens; Søren Brunak; Thorkild I A Sørensen; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

4.  A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.

Authors:  Michelle T Long; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Jiantao Ma; Rohit Loomba; Raymond T Chung; Emelia J Benjamin
Journal:  Liver Int       Date:  2018-03-12       Impact factor: 5.828

5.  Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.

Authors:  Ki-Chul Sung; Bum-Soo Kim; Yong-Kyun Cho; Dong-Il Park; Sookyoung Woo; Seonwoo Kim; Sarah H Wild; Christopher D Byrne
Journal:  BMC Gastroenterol       Date:  2012-07-06       Impact factor: 3.067

Review 6.  Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.

Authors:  Howard C Masuoka; Naga Chalasani
Journal:  Ann N Y Acad Sci       Date:  2013-01-30       Impact factor: 5.691

Review 7.  Comorbidities and Metabolic Derangement of NAFLD.

Authors:  Ki Bae Bang; Yong Kyun Cho
Journal:  J Lifestyle Med       Date:  2015-03-30

8.  Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population.

Authors:  Hyun Chin Cho
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

Review 9.  Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.

Authors:  Melania Gaggini; Mariangela Morelli; Emma Buzzigoli; Ralph A DeFronzo; Elisabetta Bugianesi; Amalia Gastaldelli
Journal:  Nutrients       Date:  2013-05-10       Impact factor: 5.717

Review 10.  Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH).

Authors:  Akinobu Takaki; Daisuke Kawai; Kazuhide Yamamoto
Journal:  Int J Mol Sci       Date:  2013-10-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.